3/31
08:00 am
bpmc
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
Low
Report
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
3/20
10:06 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $100.00 price target on the stock.
3/19
08:22 am
bpmc
Frazier Life Sciences Promotes Anna Chen to Partner [Yahoo! Finance]
Low
Report
Frazier Life Sciences Promotes Anna Chen to Partner [Yahoo! Finance]
3/18
08:08 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
3/17
08:02 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $135.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $135.00 price target on the stock.
3/7
08:17 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $150.00 price target on the stock.
3/3
11:02 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/28
10:04 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
Medium
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock.
2/28
08:49 am
bpmc
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress [Yahoo! Finance]
Medium
Report
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress [Yahoo! Finance]
2/28
08:00 am
bpmc
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress
Medium
Report
Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress
2/24
01:26 pm
bpmc
Blueprint Medicines Corporation (BPMC): Among the Oversold Biotech Stocks to Buy Now [Yahoo! Finance]
Low
Report
Blueprint Medicines Corporation (BPMC): Among the Oversold Biotech Stocks to Buy Now [Yahoo! Finance]
2/22
02:12 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/22
02:12 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/14
10:01 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/14
10:09 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
2/14
08:07 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $135.00 price target on the stock.
2/13
11:35 pm
bpmc
Q4 2024 Blueprint Medicines Corp Earnings Call [Yahoo! Finance]
Low
Report
Q4 2024 Blueprint Medicines Corp Earnings Call [Yahoo! Finance]
2/13
06:37 pm
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock, up previously from $124.00.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $128.00 price target on the stock, up previously from $124.00.
2/13
11:47 am
bpmc
Blueprint Medicines Corporation 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Blueprint Medicines Corporation 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/13
10:11 am
bpmc
Blueprint Medicines: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
Blueprint Medicines: Q4 Earnings Snapshot [Yahoo! Finance]
2/13
08:53 am
bpmc
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $133.00 price target on the stock.
Low
Report
Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $133.00 price target on the stock.
2/13
07:37 am
bpmc
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
Low
Report
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results [Yahoo! Finance]
2/13
07:00 am
bpmc
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results
Medium
Report
Blueprint Medicines Reports Fourth Quarter and Full Year 2024 Results
2/6
07:20 pm
bpmc
Should You Buy Blueprint Medicines (BPMC) After Golden Cross? [Yahoo! Finance]
Medium
Report
Should You Buy Blueprint Medicines (BPMC) After Golden Cross? [Yahoo! Finance]
2/5
08:32 am
bpmc
Blueprint Medicines to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 [Yahoo! Finance]
Low
Report
Blueprint Medicines to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025 [Yahoo! Finance]